African Journal of Diabetes medicine received 1366 citations as per google scholar report
Glycated haemoglobin (HbA1c) is the most important biochemical indicator of long-term glycaemic control in diabetes, but it is a relatively expensive test. Our study in a Nigerian diabetic clinic shows that only 24% of type 2 patients could afford to have the test. There is an urgent need to either reduce the cost of the test, or to provide subsidies to reduce the patient cost.
Select your language of interest to view the total content in your interested language
To read the issue click on a cover
